NCT00989651 2021-10-20Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerNational Cancer Institute (NCI)Phase 1 Completed431 enrolled